Sanofi Walks Away From Plavix Provincial Tender In China
This article was originally published in PharmAsia News
Executive Summary
Despite expected pricing pressure, the depth of cuts from China’s closely watched provincial tenders for newly added essential drugs still bring out surprises, and even walkaways, as reference pricing remains a threat.